This 2019 update on medications to treat opioid use disorder and opioid withdrawal provides information about extended release formulations of buprenorphine, reviews evidence for the effectiveness of lofexidene to treat withdrawal symptoms, and also includes a table with comparative costs of opioid use disorder pharmacological therapies.
A guide to strategies for paying for medication assisted treatment (MAT) for patients with opioid use disorder in community health centers. Part of the “how to pay for it” series from the California Health Care Foundation as part of the California Bridge program, this report describes strategies for how community health centers can receive reimbursement for
This 2019 report provides evidence based responses to common objections to using medication assisted treatment (MAT) for opioid use disorder.
This clinician’s guide from the California Health Care Foundation aims to provide primary care providers with “everything they need to know” about buprenorphine. It includes background information on buprenorphine’s effectiveness as a treatment for opioid use disorder and the Drug Addiction Treatment Act
This 2017 publication from the California Health Care Foundation makes the case that commercial and public health plans should make access to medication assisted treatment (MAT) a priority for patients with opioid use disorder. The report explains why MAT is so important, defines the access barriers to MAT, and provides strategies for health plans to implement in making MAT available for their patients. Funding Source: California Health Care Foundation
A guide to strategies for paying for medication assisted treatment (MAT) for patients with opioid use disorder seen in the emergency department. Part of the “how to pay for it” series from the California Health Care Foundation as part of the California Bridge program, this report describes strategies for how hospitals can receive reimbursement for MAT services provided in the emergency department.
This 2 page guide from the California chapter of the American College of Emergency Physicians provides a brief overview of administering buprenorphine or suboxone to patients in the emergency department. for treatment of opioid withdrawal. Not a guide for long term medication assisted treatment induction, but a brief overview of when and how to use these medications in an emergency department setting.
A guide to strategies for paying for medication assisted treatment (MAT) for hospitalized patients with opioid use disorder. Part of the “how to pay for it” series from the California Health Care Foundation as part of the California Bridge program, this report describes strategies for how hospitals can receive reimbursement for
This 2016 report from the California Health Care Foundation reviews evidence related to buprenorphine treatment for opioid use disorder and provides guidance for clinicians interested in creating a medication assisted treatment (MAT) program in a primary care setting. Recommendations
This 2 page guide from the California Health Care Foundation lists the “10 elements of success” in creating a buprenorphine treatment program in a primary care setting. It provides a summary of the findings from a longer report titled “Recovery Within Reach: Medication-Assisted Treatment of